Filana Therapeutics, Inc. (FLNA) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
Address
6801 N. Capital of Texas Highway
Austin, TX 78731
United States of America (the)
Phone
512 501 2444
Website
Sector
Healthcare
Industry
Biotechnology
Employees
19
First IPO Date
July 14, 2000
| Name | Title | Pay | Year Born |
| Richard Jon Barry | CEO, President & Director | 1.03M | 1959 |
| R. Christopher Cook | Chief Operating & Legal Officer | 678,975 | 1964 |
| Eric J. Schoen | Chief Financial Officer | 690,000 | 1968 |
| Angelique Bordey | Senior Vice President of Neuroscience | 0 | N/A |
| George Thornton | Senior Vice President of Technology | 0 | N/A |
| Joseph Hulihan | Chief Medical Officer | 0 | 1956 |
| Jaren Landen | Chief Clinical Development Officer | 0 | N/A |
| Jack Moore | Senior Vice President of Clinical Development | 0 | N/A |
| Michael Zamloot | Senior Vice President of Technical Operations | 0 | N/A |
| Nancy Teasdale | Head of Regulatory Affairs | 0 | N/A |
Filana Therapeutics, Inc. is a company dedicated to pioneering new pharmaceutical products and diagnostic technologies. A key area of its research is focused on creating potential treatments for Alzheimer's disease, including the investigational compounds PTI-125 and PTI-125Dx. Established by Remi Barbier in May 1998, the firm maintains its principal office in Austin, Texas.